Database Lock for Biofrontera’s Phase 3 Study of PDT in sBCC
It’s a (database) lock for Biofrontera Inc.’s Phase 3 study of Ameluz–photodynamic therapy (PDT) in combination with the BF-RhodoLED lamp in patients with superficial basal cell carcinoma (sBCC). A database lock finalizes the data collected and prevents further changes to the data. It’s usually one of the last steps before submitting the data to the […]